BURKITTS-LYMPHOMA - A MODEL FOR CLINICAL ONCOLOGY

被引：24
作者：
BOUFFET, E
FRAPPAZ, D
PINKERTON, R
FAVROT, M
PHILIP, T
机构：
[1] CTR LEON BERARD,DEPT PEDIAT ONCOL,28 RUE LAENNEC,F-69008 LYONS,FRANCE
[2] ROYAL MARSDEN HOSP,DEPT PEDIAT ONCOL,SUTTON SM2 5PX,SURREY,ENGLAND
[3] HOP NORD ST PRIEST JAREZ,DEPT PEDIAT,ST PRIEST JAREZ,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷 / 04期
关键词：
D O I：
10.1016/0277-5379(91)90397-V
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Burkitt's lymphoma, a pathological entity initially described in Africa, is the most common childhood lymphoma in western countries and represents approximately 5% of all adults lymphomas. This high grade small non-cleaved diffuse lymphoma is a model with which to study the relations between cancer and viruses, the chromosomes and the genes. Burkitt's lymphoma is also a model for clinical research which allows evaluation of the dose effect concept with chemotherapy and the role of megatherapy with autologous bone marrow rescue.
引用
收藏
页码：504 / 509
页数：6
相关论文
共 64 条
  • [51] HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PARTIAL REMISSION AFTER 1ST-LINE INDUCTION THERAPY FOR DIFFUSE NON-HODGKINS LYMPHOMA
    PHILIP, T
    HARTMANN, O
    BIRON, P
    CAHN, JY
    PEIN, F
    BORDIGONI, P
    SOUILLET, G
    GARTNER, M
    LASSET, C
    CHAUVIN, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1118 - 1124
  • [52] EFFECTIVE MULTIAGENT CHEMOTHERAPY IN CHILDREN WITH ADVANCED B-CELL LYMPHOMA - WHO REMAINS THE HIGH-RISK PATIENT
    PHILIP, T
    PINKERTON, R
    BIRON, P
    LADJADJ, Y
    BOUFFET, E
    SOUILLET, G
    PHILIPPE, N
    FRAPPAZ, D
    FREYCON, F
    CHAUVIN, F
    BRUNATMENTIGNY, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (02) : 159 - 164
  • [53] BURKITT-TYPE LYMPHOMA IN FRANCE AMONG NON-HODGKIN MALIGNANT-LYMPHOMAS IN CAUCASIAN CHILDREN
    PHILIP, T
    LENOIR, GM
    BRYON, PA
    GERARDMARCHANT, R
    SOUILLET, G
    PHILIPPE, N
    FREYCON, F
    BRUNATMENTIGNY, M
    [J]. BRITISH JOURNAL OF CANCER, 1982, 45 (05) : 670 - 678
  • [54] HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER FAILURE OF CONVENTIONAL CHEMOTHERAPY IN ADULTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA
    PHILIP, T
    ARMITAGE, JO
    SPITZER, G
    CHAUVIN, F
    JAGANNATH, S
    CAHN, JY
    COLOMBAT, P
    GOLDSTONE, AH
    GORIN, NC
    FLESH, M
    LAPORTE, JP
    MARANINCHI, D
    PICO, J
    BOSLY, A
    ANDERSON, C
    SCHOTS, R
    BIRON, P
    CABANILLAS, F
    DICKE, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (24) : 1493 - 1498
  • [55] THE ROLE OF MASSIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN BURKITTS-LYMPHOMA
    PHILIP, T
    PINKERTON, R
    HARTMANN, O
    PATTE, C
    PHILIP, I
    BIRON, P
    FAVROT, M
    [J]. CLINICS IN HAEMATOLOGY, 1986, 15 (01): : 205 - 217
  • [56] PHILIP T, 1985, BURKITTS LYMPHOMA HU, P465
  • [57] PHILIP T, 1988, 20 M INT SOC PAED ON
  • [58] PHILIP T, 1985, BURKITTS LYMPHOMA HU, P107
  • [59] SURFACE BOUND IMMUNOGLOBULINS AS A CELL MARKER IN HUMAN LYMPHOPROLIFERATIVE DISEASES
    PREUDHOMME, JL
    SELIGMANN, M
    [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 777 - +
  • [60] RODARY C, 1988, 20 M INT SOC PAED ON
1234567